首页> 外文期刊>Der Pharmacia Lettre >Pathological observations on the treatment of oral sub mucous fibrosis of curcumin gels in animal models
【24h】

Pathological observations on the treatment of oral sub mucous fibrosis of curcumin gels in animal models

机译:姜黄素凝胶口腔黏膜下纤维化治疗动物模型的病理观察

获取原文
           

摘要

Mucoadhesive gels were prepared for the treatment of oral sub mucous fibrosis, which provide effect for extended periods of time. Stress was given for improvised local action of the drug with the addition of mucoadhesive polymer in the formulation. Curcumin was taken as a model drug as it exhibits profound antitumeric & antimutogenic activity. The semisolid preparations comprised of stabilizer like sodium metabisulphite, muco retention / mucoadhesive polymers like HEC, NaCMC and equal mixture of HEC & NaCMC, and were subjected for various pysicochemical parameters like pH, spreadability, drug content uniformity, extrudability, viscosity & I.R. studies. In-vitro drug release studies were carried out in phosphate buffer (6.4 pH). Stability studies were also done at room temperature for a period of eight weeks. Among three formulations (formulation code F1 containing equal mixture of NaCMC & HEC as base, formulation code F2 containing NaCMC as base and formulation code F3 containing HEC as base), the formulation containing equal mixture of NaCMC & HEC as base showed good in-vitro release and good adhesion to oral mucosae. IR studies showed that there was no drug-excipient interaction. The in-vivo studies were carried out in two phases using 18 mice with the permission of ethical committee under the supervision and help of staff, Department of Pathology, M.R. Medical College, Gulbarga. In first phase oral sub mucous fibrosis was induced in mice using marketed Gutkha preparation and formulating into a mucoadhesive gel form and applying to mice oral mucosa with the help of cotton bud for a period of 6 months. In second phase, treatment was carried out following the above method using curcumin formulation. The tissue samples collected for 1, 3 & 6 months induction period & 1, 3 & 6 months of treatment period on 6 months oral sub mucous fibrosis induced mice. Histopathological observations reported that there was considerable induction of oral sub mucous fibrosis and excellent treatment results on curcumin usage. The results of the present study of mucoadhesive semi-solid drug design for the treatment of oral sub mucous fibrosis will be useful for drug industry for the benifit of patients suffering from oral sub mucous fibrosis.
机译:制备了用于治疗口腔粘膜下纤维化的粘膜粘附凝胶,其可延长作用时间。通过在制剂中添加粘膜粘附性聚合物来给予药物改善的局部作用的压力。姜黄素被用作模型药物,因为它具有深厚的抗姜黄素和抗突变活性。半固体制剂由稳定剂(如焦亚硫酸钠),粘液保留/粘膜粘附性聚合物(如HEC,NaCMC以及HEC和NaCMC的均等混合物)组成,并经受各种药理学参数如pH,分散性,药物含量均匀性,可挤出性,粘度和I.R.学习。在磷酸盐缓冲液(6.4 pH)中进行了体外药物释放研究。还在室温下进行了八周的稳定性研究。在三种配方中(配方代码F1中含有NaCMC和HEC的基本混合物),配方代码F2中含有NaCMC的基本碱和配方代码F3中含有NaCMC和HEC的基本混合物,表明配方良好。释放和对口腔粘膜的良好附着力。红外研究表明没有药物-赋形剂相互作用。在伦理委员会的许可下,在古尔巴加M.R.医学院病理学系的工作人员的监督和帮助下,使用18只小鼠在两个阶段中进行了体内研究。在第一阶段,使用市售的Gutkha制剂并将其配制成粘膜粘附凝胶形式并在棉花芽的帮助下应用于小鼠口腔粘膜,诱导小鼠口腔粘膜下纤维化6个月。在第二阶段,使用姜黄素制剂按照上述方法进行处理。在6个月的口腔粘膜下纤维化诱导的小鼠上收集组织样品,分别进行1、3和6个月的诱导期以及1、3和6个月的治疗期。组织病理学观察表明,口腔粘膜下纤维化有相当大的诱导作用,姜黄素的使用效果极佳。用于口腔粘膜下纤维化治疗的粘膜粘附性半固体药物设计的当前研究结果将对制药业有益于口腔粘膜下纤维化患者的受益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号